Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
Queensland Health
UBS
Express Scripts
Cerilliant
Teva
US Army
Harvard Business School

Generated: December 14, 2018

DrugPatentWatch Database Preview

Torsemide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for torsemide and what is the scope of torsemide patent protection?

Torsemide is the generic ingredient in two branded drugs marketed by Roche, Luitpold, West-ward Pharms Int, Mylan Speciality Lp, Apotex Inc, Aurobindo Pharma, Hetero Labs Ltd Iii, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for torsemide. Fifteen suppliers are listed for this compound.

Pharmacology for torsemide
Synonyms for torsemide
1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylurea
1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea
1-[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl-3-propan-2-yl-urea
1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea
1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea
1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea
1-isopropyl-3-[(4- m -toluidino-3-pyridyl) sulfonyl]urea
1-isopropyl-3-[(4-m-toluidino-3-pyridyl) sulfonyl]urea
1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea
211T406
3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-
3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-
3-pyridinesulfonamide,N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-
4-[(3-methylphenyl)amino]-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide
56211-40-6
A830961
AB0006854
AB00514011
AB00514011_10
AB00514011_11
AB00514011-09
AB2000227
AC 4464
AC-18762
AC-4464
AC1L26H7
AC1Q6UVM
AC4464
ACM1189375061
AK163579
AKOS015894937
ALBB-027267
Ambap56211-40-6
AN-919
ANW-41652
API0004454
BDBM64107
BG0484
BIDD:GT0623
BM 02015
BM-02015
BM02.015
BPBio1_001341
BRD-K30480208-001-05-2
BRN 0498515
BSPBio_001219
BSPBio_003503
C-20564
CAS-56211-40-6
CC-35108
CCG-40257
CCRIS 6736
CHEBI:9637
CHEMBL1148
cid_41781
CPD000466313
CS-2227
CT0260
CTK8B3035
D00382
D0J9XZ
DB00214
Demadex
Demadex (TN)
Demadex, Torsemide
Dilutol
DR001750
DSSTox_CID_3690
DSSTox_GSID_23690
DSSTox_RID_77149
DTXSID2023690
FT-0630689
GJ-1090
GTPL7312
HE353336
HMS1571M21
HMS1922N05
HMS2051L21
HMS2098M21
HMS2234N14
HMS3373G20
HMS3393L21
HY-B0247
I06-0056
JDL 464
JDL-464
KBio2_002256
KBio2_004824
KBio2_007392
KBio3_003008
KBioGR_000820
KBioSS_002257
KS-1123
LS-131973
Luprac
Luprac (TN)
MCULE-2734924315
MFCD00866166
MLS000759418
MLS001165687
MLS001195611
MLS001424121
MLS006010744
MolPort-002-885-870
N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide
N-({4-[(3-methylphenyl)imino]-1,4-dihydropyridin-3-yl}sulfonyl)propane-2-carbamimidic acid
N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide
N-(isopropylcarbamoyl)-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
N-[(propan-2-yl)carbamoyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
n-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide
N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
NC00238
NCGC00016879-01
NCGC00016879-02
NCGC00016879-03
NCGC00016879-04
NCGC00016879-06
NCGC00016879-07
NCGC00095141-01
NCGC00095141-02
NCGC00095141-03
NGBFQHCMQULJNZ-UHFFFAOYSA-N
Presoril
Prestwick0_001030
Prestwick1_001030
Prestwick2_001030
Prestwick3_001030
PubChem18545
PW-2132
Q-201846
R3923
s1698
SAM001246567
SC-13773
SCHEMBL41184
SMR000466313
SPBio_001063
SPBio_003080
Spectrum_001776
SPECTRUM1505211
Spectrum2_001142
Spectrum3_001832
Spectrum4_000290
Spectrum5_001699
STL388026
Sutril
TL8003646
Toradiur
Torasemida
Torasemida [INN-Spanish]
Torasemide
Torasemide (JAN/INN)
Torasemide anhydrous, European Pharmacopoeia (EP) Reference Standard
Torasemide for system suitability, European Pharmacopoeia (EP) Reference Standard
Torasemide N
Torasemide, Anhydrous
Torasemidum
Torasemidum [INN-Latin]
Torem
Torocard
Torrem
Torsemide (Demadex)
Torsemide (USP)
Torsemide [USAN:USP]
Torsemide [USAN]
Torsemide, >=98% (HPLC), solid
Torsemide, United States Pharmacopeia (USP) Reference Standard
Tox21_110662
Tox21_110662_1
TR-019752
Unat
UNII-W31X2H97FB
VA11897
W31X2H97FB
ZINC5823
ZX-AN025776

US Patents and Regulatory Information for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc TORSEMIDE torsemide TABLET;ORAL 076894-002 May 31, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma TORSEMIDE torsemide TABLET;ORAL 078249-003 Oct 17, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma TORSEMIDE torsemide TABLET;ORAL 078249-004 Oct 17, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva TORSEMIDE torsemide TABLET;ORAL 076110-001 May 14, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Inc TORSEMIDE torsemide TABLET;ORAL 076894-003 May 31, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-001 Aug 23, 1993 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ➤ Sign Up ➤ Sign Up
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
Queensland Health
US Department of Justice
Argus Health
Mallinckrodt
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.